These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Tricyclic antidepressants and monoamine oxidase inhibitors - do they still have a role in the treatment of depression?]. Pitchot W; Scantamburlo G; Ansseau M Rev Med Liege; 2011 Mar; 66(3):144-52. PubMed ID: 21560431 [TBL] [Abstract][Full Text] [Related]
47. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification. Sheehan DV J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Murphy DL; Siever LJ; Insel TR Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):3-13. PubMed ID: 2986199 [TBL] [Abstract][Full Text] [Related]
50. New antidepressants and trends in the pharmacotherapy of depressive disorders. Zarifian E; Rigal F Psychiatr Clin North Am; 1983 Mar; 6(1):129-39. PubMed ID: 6889169 [No Abstract] [Full Text] [Related]
51. Rational use of antidepressants. Perry PJ; Alexander B Prim Care; 1987 Dec; 14(4):773-83. PubMed ID: 3324134 [TBL] [Abstract][Full Text] [Related]
54. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182 [TBL] [Abstract][Full Text] [Related]
55. [Various aspects of the differential therapy of circular depressions]. Prokhorova IS Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):570-4. PubMed ID: 4002949 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular considerations in selection of anti-panic pharmacotherapy. Taylor CB; Hayward C J Psychiatr Res; 1990; 24 Suppl 2():43-9. PubMed ID: 1980698 [TBL] [Abstract][Full Text] [Related]